A human-type nonalcoholic steatohepatitis model with advanced fibrosis in rabbits.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  American Journal of Pathology

• Publication date

  2010-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2353/ajpath.2010.090895PMID 20489159PMCID PMC2893659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Transition : Evaluating the postcommunist experience

  2017cited by this paper
• A rabbit model of pediatric nonalcoholic steatohepatitis: the role of adiponectin.

  2009cited by this paper
• Metabolic and histological features of non‐alcoholic fatty liver disease patients with different serum alanine aminotransferase levels

  2009cited by this paper
• Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid‐lowering effect

  2009cited by this paper
• The Transition from Fatty Liver to NASH Associates with SAMe Depletion in db/db Mice Fed a Methionine Choline-Deficient Diet

  2008cited by this paper
• Gene expression in human NAFLD.

  2008cited by this paper
• Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease.

  2008cited by this paper
• CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima.

  2008cited by this paper
• The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1.

  2008cited by this paper
• Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia.

  2008influential reference
• Attenuation of acute and chronic liver injury in rats by iron-deficient diet.

  2008cited by this paper
• Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet

  2008cited by this paper
• Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.

  2007cited by this paper
• Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium.

  2007influential reference
• A lipidomic analysis of nonalcoholic fatty liver disease

  2007cited by this paper
• Loss of the glycine N‐methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice

  2007cited by this paper
• Role of S‐adenosyl‐L‐methionine in liver health and injury

  2007cited by this paper
• TLR4 enhances TGF-beta signaling and hepatic fibrosis.

  2007cited by this paper
• Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome

  2007cited by this paper
• Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis.

  2007cited by this paper
• TLR4 enhances TGF-β signaling and hepatic fibrosis

  2007cited by this paper
• Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe.

  2007cited by this paper
• In Vivo Responsiveness to Ezetimibe Correlates with Niemann-Pick C1 Like-1 (NPC1L1) Binding Affinity: Comparison of Multiple Species NPC1L1 Orthologs

  2007cited by this paper
• Erythrophagocytosis by liver macrophages (Kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis: implications for the pathogenesis of human nonalcoholic steatohepatitis.

  2007cited by this paper
• Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis.

  2006cited by this paper
• Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.

  2006cited by this paper
• Inhibition of intestinal cholesterol absorption by ezetimibe is a novel therapeutic target for fatty liver.

  2006influential reference
• Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease.

  2006cited by this paper
• Systemic Markers of Lipid Peroxidation and Antioxidants in Patients with Nonalcoholic Fatty Liver Disease

  2005cited by this paper
• One-Year Intense Nutritional Counseling Results in Histological Improvement in Patients with Nonalcoholic Steatohepatitis: A Pilot Study

  2005cited by this paper
• Adipokines in NASH: Postprandial lipid metabolism as a link between adiponectin and liver disease

  2005cited by this paper
• Tumour necrosis factor α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice

  2005cited by this paper
• Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4.

  2005cited by this paper
• Glutathione metabolism and antioxidant enzymes in patients affected by nonalcoholic steatohepatitis.

  2005cited by this paper
• Nonalcoholic fatty liver disease

  2005cited by this paper
• Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.

  2005cited by this paper
• Toll-like receptor signalling

  2004influential reference
• Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis.

  2004cited by this paper
• Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot study.

  2004influential reference
• Niemann-Pick C1 Like 1 (NPC1L1) Is the Intestinal Phytosterol and Cholesterol Transporter and a Key Modulator of Whole-body Cholesterol Homeostasis*

  2004cited by this paper
• Systemic Levels of Lipid Peroxidation and Its Metabolic and Dietary Correlates in Patients with Nonalcoholic Steatohepatitis

  2004cited by this paper
• The effect of diet enriched with alpha-linolenic acid on soluble cellular adhesion molecules in dyslipidaemic patients.

  2004cited by this paper
• Toll‐Like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells

  2003cited by this paper
• The importance of iron and copper accumulation in the pathogenesis of non-alcoholic steatohepatitis.

  2003cited by this paper
• NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis.

  2003cited by this paper
• Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

  2003cited by this paper
• Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis

  2003cited by this paper
• Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

  2003cited by this paper
• EVALUATION OF THE EFFICACY, SAFETY, AND TOLERABILITY OF EZETIMIBE IN PRIMARY HYPERCHOLESTEROLAEMIA: A POOLED ANALYSIS FROM TWO CONTROLLED PHASE III CLINICAL STUDIES

  2003cited by this paper
• Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

  2002cited by this paper
• In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases.

  2002influential reference
• Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation

  2001cited by this paper
• Effect of a moderately energy-restricted diet on obese patients with fatty liver.

  2001cited by this paper
• Oxidative stress-related molecules and liver fibrosis.

  2001cited by this paper
• The role of Kupffer cell oxidant production in early ethanol-induced liver disease.

  2001cited by this paper
• Characterization of a Stellate Cell Activation-associated Protein (STAP) with Peroxidase Activity Found in Rat Hepatic Stellate Cells*

  2001cited by this paper
• Proteome analysis of rat hepatic stellate cells

  2000cited by this paper
• Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury*

  2000cited by this paper
• Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

  1999cited by this paper
• Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

  1999cited by this paper
• Development of a new, simple rat model of early alcohol‐induced liver injury based on sensitization of kupffer cells

  1999cited by this paper
• The hepatic perisinusoidal stellate cell.

  1997cited by this paper
• Centrolobular liver fibrosis in the hypercholesterolemic rabbit

  1996cited by this paper
• Nonalcoholic fatty liver disease.

  1986cited by this paper
• Cellular Pathology of Progressive Atherosclerosis in the WHHL Rabbit: An Animal Model of Familial Hypercholesterolemia

  1983cited by this paper
• Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

  1980cited by this paper
• "Sternzellen" in the liver: perisinusoidal cells with special reference to storage of vitamin A.

  1971cited by this paper
• Materials and Methods Figs. S1 to S4 Tables S1 and S2 References Niemann-pick C1 like 1 Protein Is Critical for Intestinal Cholesterol Absorption

  year unknowncited by this paper

• Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models.

  2026cites this paper
• GLP-1 RAs for Treating Metabolic Dysfunction-Associated Steatosis Liver Disease: From GLP-1 Discovery to FDA Approval: A Comprehensive Narrative Review

  2026cites this paper
• An overview of the cholesterol metabolism and its proinflammatory role in the development of MASLD

  2024influential citation
• Vegetables Spices Fermentation Extract Inhibit NAFLD Development by Attenuation of Steatosis through Suppression of C/EBPα and TNFα mRNA Expression

  2024cites this paper
• The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease

  2023cites this paper
• Multiple time‐dependent pathophysiological changes in a rabbit model of high‐fat diet‐induced hyperlipidemia

  2023cites this paper
• Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm

  2022cites this paper
• In vitro models for non-alcoholic fatty liver disease: Emerging platforms and their applications

  2021cites this paper
• Hepatoprotective effect of pomegranate (Punica granatum l.) in a rabbit model of steatohepatitis

  2021cites this paper
• Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH

  2021cites this paper
• Hyperlipidemic Rabbit Models for Anti-Atherosclerotic Drug Development

  2020influential citation
• Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease?

  2020influential citation
• Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: could it be essential?

  2020cites this paper
• A Diet Rich in Saturated Fat and Cholesterol Aggravates the Effect of Bacterial Lipopolysaccharide on Alveolar Bone Loss in a Rabbit Model of Periodontal Disease

  2020cites this paper
• Mechanistic study of attenuation of monosodium glutamate mixed high lipid diet induced systemic damage in rats by Coccinia grandis

  2020cites this paper
• Dietary cholesterol does not break your heart but kills your liver

  2018cites this paper
• Establishment of a novel non-alcoholic fatty liver disease model using cholesterol-fed rabbits with reference to the potential role of endoplasmic reticulum stress

  2018cites this paper
• EFFECT OF COMMON CARP AND AFRICAN CATFISH OILS ON RATS FED ON HIGH-FAT DIET

  2018cites this paper
• Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease

  2017cites this paper
• New Potential Biomarker Proteins for Alcoholic Liver Disease Identified by a Comparative Proteomics Approach

  2017cites this paper
• Normal weight dyslipidemia: Is it all about the liver?

  2016influential citation
• Tree shrew (Tupaia belangeri chinensis), a novel non-obese animal model of non-alcoholic fatty liver disease

  2016cites this paper
• Electronegative LDL is linked to high-fat, high-cholesterol diet-induced nonalcoholic steatohepatitis in hamsters.

  2016cites this paper
• High-fat but not sucrose intake is essential for induction of dyslipidemia and non-alcoholic steatohepatitis in guinea pigs

  2016cites this paper
• Development of non-invasive method for assessment of hepatic steatosis.

  2016cites this paper
• Nonalcoholic Steatohepatitis: A Search for Factual Animal Models

  2015cites this paper
• Cholesterol induces lipoprotein lipase expression in a tree shrew (Tupaia belangeri chinensis) model of non-alcoholic fatty liver disease

  2015cites this paper
• Guinea Pigs Present Hypercholesterolemia, Hepatic Steatosis and Liver Injury Con- gruent with Cholesterol-Induced Non-Alcoholic Fatty Liver Disease Following a Dietary Cholesterol Challenge

  2015cites this paper
• Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit.

  2014cites this paper
• A Vaccine Targeted at CETP Alleviates High Fat and High Cholesterol Diet-Induced Atherosclerosis and Non-Alcoholic Steatohepatitis in Rabbit

  2014cites this paper
• Influence of ezetimibe on selected parameters of oxidative stress in rat liver subjected to ischemia/reperfusion

  2014cites this paper
• Should we lower lipids in nonalcoholic fatty liver disease?

  2014cites this paper
• Nutritional Induction of Nonalcoholic Fatty Liver Disease

  2014cites this paper
• Should we Lower Lipids in Nafld?

  2013cites this paper
• Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease

  2013cites this paper
• Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome.

  2013cites this paper
• Investigating the Metabolic and Pathophysiological Ramifications of Elevated Dietary Cholesterol and Macronutrient Manipulation in Guinea Pigs (Cavia porcellus) with Non-alcoholic Fatty Liver Disease (NAFLD)

  2013cites this paper
• In-vivo study of quantitative ultrasound parameters in fatty rabbit livers

  2012cites this paper
• Role of hepatic stellate cells in fibrogenesis in a model of pomegranate-treated fatty liver induced by junk food in male albino rats immunohistochemical and electron microscopic study

  2012cites this paper
• The Impact of Four Potential Herbal Foods on Modifying Metabolic Parameters in Hypercholesterolemic Rats Model

  2012cites this paper
• Evaluation of Fbxw7 expression and its correlation with expression of SREBP-1 in a mouse model of NAFLD.

  2012cites this paper
• Non-alcoholic steatohepatitis: what can we learn from animal models?

  2012cites this paper
• Contribution EX VIVO STUDY OF QUANTITATIVE ULTRASOUND PARAMETERS IN FATTY RABBIT LIVERS

  2012influential citation
• Animal models of nonalcoholic fatty liver disease

  2011cites this paper
• Metabolic therapy: lessons from liver diseases.

  2011cites this paper
• Alteration of liver fat metabolism following irinotecan plus 5-fluorouracil treatment

  2011cites this paper
• Close correlation of liver stiffness with collagen deposition and presence of myofibroblasts in non‐alcoholic fatty liver disease

  2011cites this paper
• Challenging the rodent hegemony: a new rabbit model of nonalcoholic steatohepatitis.

  2010cites this paper
• Niemann-Pick C1-Like 1 deletion in mice prevents high-fat diet-induced fatty liver by reducing lipogenesis[S]

  2010cites this paper